Frequently Asked Questions (FAQ)
What type of exercise program is the patient taking
The patient is receiving daily
physical therapy. He is increasing his muscle strength by utilizing
isometric exercises. He is doing flexion and extension exercises
as well as light weight lifting with his arms and legs.
Why has a quiet period been implemented?
Why isnt information being released about the patient?
Throughout the planning of the AbioCor clinical trial,
ABIOMED and all five of the clinical sites, including Jewish Hospital
and the University of Louisville have wished and agreed to give
priority to the patient and the familys needs. It is our judgment
that the foremost concern is the quality of care for the patient
as well as protection of the privacy, confidentiality and dignity
of the patient and his family. In that regard, throughout this endeavor
and as stated in numerous other media briefings, we have wished
to undertake a very controlled approach to media releases. We would
note that the patient and the family expressed to the clinical team
at the time of evaluation that they did not wish any publicity until
such time as they could comfortably respond. As of yesterday, July
10, the family again expressed their desire for Jewish Hospital
and the doctors to continue with the quiet period. We will continue
with the quiet period and non-disclosure of patient and family information
until such time as it is felt appropriate and reflective of changes
in the patients condition that warrant discussion.
Why has the hospital over the past weekend referred
calls to ABIOMED rather than responding to questions?
As had previously been announced, we wished to maintain
a quiet period as it relates to the patient condition and other
matters concerning patient care. It was appropriate to reference
ABIOMED since the hospital recognized that there could be research
and or technical questions concerning the ABIOMED device and that
those most appropriately would be answered by ABIOMED.
Who is paying for the patients care?
Consistent with patient confidentiality, the hospital
has elected to not discuss reimbursement for the patients
care just as they would not release payor type or reimbursement
schedules for any other patient receiving care at Jewish Hospital
without family consent. As guaranteed in the clinical trials
Informed Consent (available for review on ABIOMEDs website
the patient will bear no personal financial responsibility.
Please provide info regarding the patient advocate.
As has been stated from the beginning, ABIOMED has
required of all participating clinical centers that a patient advocate
be made available to all prospective participants in the AbioCor
trial, in order to assure appropriate attention to ethical and moral
issues associated with the trial. The University and Jewish Hospital
have enthusiastically embraced this concept. More information concerning
the formation of the patient advocacy foundation can be obtained
by contacting E. Haavi Morreim, Ph.D., during the weekday at 901-448-5725
or during the evenings at 901-755-7479.